Abboud R T, Ofulue A F, Sansores R H, Muller N L
Respiratory Division, University of British Columbia, Vancouver Hospital and Health Sciences Centre, Canada.
Chest. 1998 May;113(5):1257-63. doi: 10.1378/chest.113.5.1257.
To evaluate the relationship between alveolar macrophage (AM) elastase and plasminogen activator (PA) activities (considered to be potential pathogenetic factors in emphysema) and the development of emphysema in smokers.
Thirty-four healthy smokers >35 years of age (mean+/-SD, 46+/-7 years), with a mean+/-SD of 33+/-10 pack-years of smoking, who were recruited as volunteers.
Subjects had lung function testing and BAL to obtain AMs; limited high-resolution CT scans of the chest were obtained in 32 subjects to assess the presence of emphysema. Macrophage PA and elastase were determined using AM cultured on (131)I-fibrin-coated plates and 3H-elastin-coated plates, respectively.
The number of AMs recovered per milliliter of BAL was significantly greater in the 16 subjects with CT evidence of mild emphysema than the 16 subjects without evidence of emphysema (669+/-301 x 10(3)/mL vs 414+/-268x 10(3)/mL; p=0.01). There was no significant difference between AM elastase or PA activities in the 16 subjects with CT evidence of mild emphysema, when compared with the 16 subjects who had no CT evidence of emphysema (elastase, 2.72+/-1.35 microg vs 2.49+/-0.91 microg elastin per 10(6) AMs per first 24 h; PA, 0.375+/-0.126 vs 0.344+/-0.096 urokinase units/10(6) AMs). There was no significant correlation between levels of PA or elastase activities and FEV1, FEV1/FVC, forced expiratory flow rate between 25% and 75% of the FVC; PA activity but not elastase activity had a significant negative correlation (r=-0.47, p<0.01) with diffusion of carbon monoxide (DCO). The macrophage count in BAL had a significant negative correlation with DCO percent predicted (r=-0.61, p<0.001).
The findings suggest that the number of AMs recovered per milliliter of BAL (presumably indicating the number in the alveolar spaces) is related to the development of emphysema in smokers as indicated by CT scan of the chest and DCO. The results also suggest that the level of PA enzyme activity in AMs may be a pathogenetic factor in the decrease in DCO in smokers.
评估肺泡巨噬细胞(AM)弹性蛋白酶和纤溶酶原激活物(PA)活性(被认为是肺气肿潜在的致病因素)与吸烟者肺气肿发生发展之间的关系。
34名年龄大于35岁(平均±标准差,46±7岁)的健康吸烟者,平均±标准差吸烟量为33±10包年,招募为志愿者。
受试者进行肺功能测试和支气管肺泡灌洗(BAL)以获取AM;32名受试者进行胸部有限高分辨率CT扫描以评估肺气肿的存在。分别使用在¹³¹I-纤维蛋白包被板和³H-弹性蛋白包被板上培养的AM来测定巨噬细胞PA和弹性蛋白酶。
16名有CT证据显示轻度肺气肿的受试者每毫升BAL回收的AM数量明显多于16名无肺气肿证据的受试者(669±301×10³/mL对414±268×10³/mL;p = 0.01)。16名有CT证据显示轻度肺气肿的受试者与16名无CT证据显示肺气肿的受试者相比,AM弹性蛋白酶或PA活性无显著差异(弹性蛋白酶,每头24小时每10⁶个AM中2.72±1.35μg对2.49±0.91μg弹性蛋白;PA,0.375±0.126对0.344±0.096尿激酶单位/10⁶个AM)。PA或弹性蛋白酶活性水平与第一秒用力呼气容积(FEV₁)、FEV₁/用力肺活量(FVC)、FVC 25%至75%之间的用力呼气流量无显著相关性;PA活性而非弹性蛋白酶活性与一氧化碳弥散量(DCO)有显著负相关(r = -0.47,p < 0.01)。BAL中的巨噬细胞计数与预计DCO百分比有显著负相关(r = -0.61,p < 0.001)。
研究结果表明,每毫升BAL回收的AM数量(可能表明肺泡腔中的数量)与胸部CT扫描和DCO所示吸烟者肺气肿的发生发展有关。结果还表明,AM中PA酶活性水平可能是吸烟者DCO降低的致病因素。